These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 30597409)

  • 1. The On-Off chiral mesoporous silica nanoparticles for delivering achiral drug in chiral environment.
    Fan N; Liu R; Ma P; Wang X; Li C; Li J
    Colloids Surf B Biointerfaces; 2019 Apr; 176():122-129. PubMed ID: 30597409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superiority of amino-modified chiral mesoporous silica nanoparticles in delivering indometacin.
    Li J; Guo Y; Li H; Shang L; Li S
    Artif Cells Nanomed Biotechnol; 2018 Aug; 46(5):1085-1094. PubMed ID: 28776393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concealed body mesoporous silica nanoparticles for orally delivering indometacin with chiral recognition function.
    Zhou J; Zhu F; Li J; Wang Y
    Mater Sci Eng C Mater Biol Appl; 2018 Sep; 90():314-324. PubMed ID: 29853097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enlarged Pore Size Chiral Mesoporous Silica Nanoparticles Loaded Poorly Water-Soluble Drug Perform Superior Delivery Effect.
    Guo Y; Gou K; Yang B; Wang Y; Pu X; Li S; Li H
    Molecules; 2019 Sep; 24(19):. PubMed ID: 31575047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Superiority of L-tartaric Acid Modified Chiral Mesoporous Silica Nanoparticle as a Drug Carrier: Structure, Wettability, Degradation, Bio-Adhesion and Biocompatibility.
    Hu B; Wang J; Li J; Li S; Li H
    Int J Nanomedicine; 2020; 15():601-618. PubMed ID: 32099354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amino functionalized chiral mesoporous silica nanoparticles for improved loading and release of poorly water-soluble drug.
    Wang X; Li C; Fan N; Li J; Zhang H; Shang L; He Z; Sun J
    Asian J Pharm Sci; 2019 Jul; 14(4):405-412. PubMed ID: 32104469
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enantioselective Oral Absorption of Molecular Chiral Mesoporous Silica Nanoparticles.
    Wang Y; Zhao L; Dai Y; Xu M; Zhou R; Zhou B; Gou K; Zeng R; Xu L; Li H
    Adv Mater; 2023 Dec; 35(49):e2307900. PubMed ID: 37839052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chiral Nanosilica Drug Delivery Systems Stereoselectively Interacted with the Intestinal Mucosa to Improve the Oral Adsorption of Insoluble Drugs.
    Chen X; Cheng Y; Pan Q; Wu L; Hao X; Bao Z; Li X; Yang M; Luo Q; Li H
    ACS Nano; 2023 Feb; 17(4):3705-3722. PubMed ID: 36787639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxyl-functionalized mesoporous silica nanoparticles for the controlled delivery of poorly water-soluble non-steroidal anti-inflammatory drugs.
    Gou K; Wang Y; Guo X; Wang Y; Bian Y; Zhao H; Guo Y; Pang Y; Xie L; Li S; Li H
    Acta Biomater; 2021 Oct; 134():576-592. PubMed ID: 34280558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incorporation of indomethacin nanoparticles into 3-D ordered macroporous silica for enhanced dissolution and reduced gastric irritancy.
    Hu Y; Zhi Z; Wang T; Jiang T; Wang S
    Eur J Pharm Biopharm; 2011 Nov; 79(3):544-51. PubMed ID: 21767643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A pH-responsive chiral mesoporous silica nanoparticles for delivery of doxorubicin in tumor-targeted therapy.
    Gou K; Xin W; Lv J; Ma Z; Yang J; Zhao L; Cheng Y; Chen X; Zeng R; Li H
    Colloids Surf B Biointerfaces; 2023 Jan; 221():113027. PubMed ID: 36410192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of bare and amino modified mesoporous silica@poly(ethyleneimine)s xerogel as indomethacin carrier: Superiority of amino modification.
    Li J; Xu L; Wang H; Yang B; Liu H; Pan W; Li S
    Mater Sci Eng C Mater Biol Appl; 2016 Feb; 59():710-716. PubMed ID: 26652425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual response to pH and chiral microenvironments for the release of a flurbiprofen-loaded chiral self-assembled mesoporous silica drug delivery system.
    Wu L; Gou K; Guo X; Guo Y; Chen M; Hou J; Li S; Li H
    Colloids Surf B Biointerfaces; 2021 Mar; 199():111501. PubMed ID: 33338882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small molecules modified mesoporous silica nanoparticles orally deliver indomethacin with synergistic effect.
    Yin S; Cai L; Li X; Lin K; Shi X; Zhang H; Wang L; Li J
    Eur J Pharm Sci; 2024 Apr; 195():106719. PubMed ID: 38309442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug delivery formulations of ordered and nonordered mesoporous silica: comparison of three drug loading methods.
    Limnell T; Santos HA; Mäkilä E; Heikkilä T; Salonen J; Murzin DY; Kumar N; Laaksonen T; Peltonen L; Hirvonen J
    J Pharm Sci; 2011 Aug; 100(8):3294-3306. PubMed ID: 21520084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Controlled release of silyl ether camptothecin from thiol-ene click chemistry-functionalized mesoporous silica nanoparticles.
    Yan Y; Fu J; Wang T; Lu X
    Acta Biomater; 2017 Mar; 51():471-478. PubMed ID: 28131940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ordered nanoporous silica as carriers for improved delivery of water insoluble drugs: a comparative study between three dimensional and two dimensional macroporous silica.
    Wang Y; Zhao Q; Hu Y; Sun L; Bai L; Jiang T; Wang S
    Int J Nanomedicine; 2013; 8():4015-31. PubMed ID: 24174875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biomimetic synthesized chiral mesoporous silica: Structures and controlled release functions as drug carrier.
    Li J; Xu L; Yang B; Bao Z; Pan W; Li S
    Mater Sci Eng C Mater Biol Appl; 2015 Oct; 55():367-72. PubMed ID: 26117767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pH-sensitive silica nanoparticles for colon-specific delivery and controlled release of catechin: Optimization of loading efficiency and in vitro release kinetics.
    Kassem AM; Almukainzi M; Faris TM; Ibrahim AH; Anwar W; Elbahwy IA; El-Gamal FR; Zidan MF; Akl MA; Abd-ElGawad AM; Elshamy AI; Elmowafy M
    Eur J Pharm Sci; 2024 Jan; 192():106652. PubMed ID: 38008226
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ammonium salt modified mesoporous silica nanoparticles for dual intracellular-responsive gene delivery.
    Li Y; Hei M; Xu Y; Qian X; Zhu W
    Int J Pharm; 2016 Sep; 511(2):689-702. PubMed ID: 27426108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.